M. Maffini

515 total citations
7 papers, 392 citations indexed

About

M. Maffini is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, M. Maffini has authored 7 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 4 papers in Pharmacology and 2 papers in Clinical Psychology. Recurrent topics in M. Maffini's work include Schizophrenia research and treatment (5 papers), Treatment of Major Depression (4 papers) and Electroconvulsive Therapy Studies (3 papers). M. Maffini is often cited by papers focused on Schizophrenia research and treatment (5 papers), Treatment of Major Depression (4 papers) and Electroconvulsive Therapy Studies (3 papers). M. Maffini collaborates with scholars based in Italy and United Kingdom. M. Maffini's co-authors include Silvia Paletta, Filippo Dragogna, A. Carlo Altamura, Chiara Di Pace, Montserrat Maurí, Alessandro Colasanti, Massimo Carlo Mauri, Chiara Rovera, S.R. Bareggi and Alfredo Carlo Altamura and has published in prestigious journals such as Progress in Neuro-Psychopharmacology and Biological Psychiatry, Expert Opinion on Drug Metabolism & Toxicology and Asian Journal of Psychiatry.

In The Last Decade

M. Maffini

7 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Maffini Italy	6	193	78	70	69	58	7	392
Filippo Dragogna Italy	8	209 1.1×	62 0.8×	55 0.8×	56 0.8×	56 1.0×	13	371
L.S. Volonteri Italy	10	304 1.6×	74 0.9×	85 1.2×	94 1.4×	50 0.9×	17	479
Shubhra Mace United Kingdom	9	277 1.4×	59 0.8×	93 1.3×	125 1.8×	25 0.4×	14	467
Toshiaki Aoshima Japan	11	107 0.6×	55 0.7×	35 0.5×	112 1.6×	47 0.8×	21	345
Silvia Paletta Italy	12	382 2.0×	96 1.2×	112 1.6×	128 1.9×	70 1.2×	29	673
Charles Griffin United States	2	97 0.5×	84 1.1×	40 0.6×	38 0.6×	49 0.8×	2	401
Matteo Caloro Italy	8	106 0.5×	45 0.6×	61 0.9×	51 0.7×	27 0.5×	14	243
Harriet Quigley United Kingdom	4	171 0.9×	69 0.9×	63 0.9×	224 3.2×	32 0.6×	6	428
Takaharu Azekawa Japan	11	147 0.8×	52 0.7×	68 1.0×	87 1.3×	105 1.8×	33	475
L. G. Schmidt Germany	10	165 0.9×	93 1.2×	35 0.5×	47 0.7×	48 0.8×	20	370

Countries citing papers authored by M. Maffini

Since Specialization

Citations

This map shows the geographic impact of M. Maffini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Maffini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Maffini more than expected).

Fields of papers citing papers by M. Maffini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Maffini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Maffini. The network helps show where M. Maffini may publish in the future.

Co-authorship network of co-authors of M. Maffini

This figure shows the co-authorship network connecting the top 25 collaborators of M. Maffini. A scholar is included among the top collaborators of M. Maffini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Maffini. M. Maffini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Mauri, Massimo Carlo, M. Maffini, Chiara Di Pace, et al.. (2014). “Long-acting” olanzapine in maintenance therapy of schizophrenia: A study with plasma levels. International Journal of Psychiatry in Clinical Practice. 19(2). 99–105. 12 indexed citations

2.

Maurí, Montserrat, Silvia Paletta, M. Maffini, et al.. (2014). Review article: CLINICAL PHARMACOLOGY OF ATYPICAL ANTIPSYCHOTICS: AN UPDATE. 1 indexed citations

3.

Maurí, Montserrat, Silvia Paletta, M. Maffini, et al.. (2014). Clinical pharmacology of atypical antipsychotics: an update. PubMed. 13. 1163–91. 208 indexed citations

4.

Altamura, Alfredo Carlo, et al.. (2013). Understanding the pharmacokinetics of anxiolytic drugs. Expert Opinion on Drug Metabolism & Toxicology. 9(4). 423–440. 73 indexed citations

5.

Paletta, Silvia, et al.. (2013). Suicide attempts in schizophrenic patients: Clinical variables. Asian Journal of Psychiatry. 6(5). 421–427. 26 indexed citations

6.

Rovera, Chiara, et al.. (2011). Aggression and psychopharmacological treatments in major psychosis and personality disorders during hospitalisation. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35(7). 1631–1635. 12 indexed citations

7.

Fiorentini, A., L.S. Volonteri, Filippo Dragogna, et al.. (2011). Substance-Induced Psychoses: A Critical Review of the Literature. Current Drug Abuse Reviews. 4(4). 228–240. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact